StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Allergen (AGN) PT Raised to $280 at Leerink Partners Following 4Q
February 9, 2017 8:07 AM
Leerink Partners raised its price target on Allergen (NYSE: AGN) to ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst EPS Change
Analyst EPS View
Analyst PT Change
Next Articles
S&P 500 ekes out gain while banks drag on Dow
February 8, 2017 7:28 AM
Allergan says U.S. tax reform unlikely in 2017, sees strong year
February 8, 2017 7:17 AM
Allergan (AGN) Tops Q4 EPS by 14c; Guides Above the Street
February 8, 2017 7:02 AM
Allergan Reports Strong 2016 Finish with 7% Increase in GAAP Net Revenues to $3.9 Billion in Fourth Quarter 2016
February 8, 2017 7:00 AM
Allergan (AGN) call put ratio 2 calls to 1 put into Q4
February 7, 2017 8:43 AM
Allergan Launches See America(SM), a Bold Initiative Furthering the Fight Against Preventable Blindness
February 7, 2017 7:55 AM
Mizuho Reiterates Buy Rating on Allergan (AGN) Ahead of Earnings
February 7, 2017 6:26 AM
